Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX°) in healthy volunteers

Artigo

2004; Springer Science+Business Media; Volume: 112; Issue: 7 Linguagem: Inglês

10.1007/s00702-004-0234-8

ISSN

1435-1463

Autores

Wolfgang H. Jost, André Kohl, S. Brinkmann, Georg Comes,

Tópico(s)

Hereditary Neurological Disorders

Ver no editor

Altmetric

PlumX